Christopher Glazek October 1, 2013 Studies have shown that the H.I.V. treatment “pre-exposure prophylaxis,” or PrEP for short, has been effective, but adoption of the drug has been slow. Ken Mayer, HMS professor of medicine, is quoted. Read full article
How Much Are Concierge Medicine and Direct Primary Care Growing? December 18, 2025 Study quantifies surge transforming U.S. health care
Harvard Medical School’s Top Science News of 2025 December 18, 2025 10 biomedical discoveries that expand knowledge, may improve health
Researchers Discover Bias in AI Models That Analyze Pathology Samples December 16, 2025 The team created a new tool that reduces bias and improves cancer diagnosis across populations
